Czechia, April 27 -- Czechia based Fresenius Kabi s.r.o. has secured contract from Fakultni nemocnice Plzen for Antineoplastic and immunomodulating agents - Antineoplastica and immunomodulators 2026. The value of the contract is worth 1068592000 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....